Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial | Zendy

AI Assistant Blog Pricing

Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.